We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Gene and Cell Therapy – Products

Cell therapy.
Product News

OrganaBio Launches On-Demand GMP-Compliant Hematopoietic Stem Cell Source for Advanced Therapy Manufacturing

First commercial source of on-demand GMP CD34+ hematopoietic stem cells for clinical manufacturing in the industry. OrganaBio leveraging years of in-house tissue sourcing and cell isolation experience to produce high-quality GMP-compliant cells.
Cytokines for BEST Cell Culture
Product
Advertisement

BEST-IN-CLASS Cytokines for BEST Cell Culture

Click here for further information!
resDetect™ Manufacturing Process Residue Detection Solutions
Product
Advertisement

Emphasizing Bio-Pharmaceutical CMC Residue Quality Control

resDetect™ is a series of reagent kits designed to follow international legal and regulatory requirements and guidelines for the detection of residual components in the biopharmaceutical manufacturing process.
A section of RNA split from a DNA strand.
Whitepaper

Gene Therapy: A New Frontier in Disease-Modifying Therapies

This article explores major advances in disease modification for illnesses that still lack effective treatments, as well as some challenges and approaches to overcome them.
Viruses.
Product News

Viroclinics-DDL Changes Name to Cerba Research

Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands), proudly announces changing its name to Cerba Research as of the 1st of April 2024.
Cell therapy.
Product News

ProteoNic Announces Partnership With Ginkgo Bioworks and Joins the Ginkgo Technology Network

ProteoNic Biosciences, announced a partnership with Ginkgo Bioworks (NYSE: DNA). This strategic alliance will grant Ginkgo Bioworks’ customers access to ProteoNic's state of the art vector technology in the field of protein production.
Two scientists in a lab.
Product News

BioSenic Releases Details of Optimized Administration Approach Ahead of Planned Phase 3 Trial of OATO

New data builds on earlier findings from a post-hoc Phase 2 analysis that helped reposition BioSenic’s oral arsenic trioxide (OATO) program for pivotal trials.
Microsart® ATMP Sterile Release Kit: Rapid Sterile DNA Testing for Microbes
Product
Advertisement

Microsart® ATMP Sterile Release: PCR-Based Rapid Sterility Testing for Short Shelf-Life Products

Ensure the highest standard of patient safety with the Microsart® ATMP Sterile Release Kit, the definitive solution for rapid detection of bacterial and fungal contamination in cell therapy products. Our kit combines the precision of Microsart® ATMP Bacteria and Microsart® ATMP Fungi tests, utilizing the trusted real-time PCR method to deliver accurate results within just 3 hours.

With the Microsart® ATMP Sterile Release Kit, you can confidently release contamination-free cell therapy products, significantly reducing the reliance on prophylactic antibiotics and safeguarding patient health. Our unique kit stands alone in the market, offering an unmatched level of testing that no other product can provide.
AKTA System
App Note / Case Study

Single-Use Technology Designed for Small Batches in Gene Therapy Manufacturing

But how do you purify small volumes for preclinical and clinical studies without losing too much to processing or leaving capacity unused?
A PCR Machine.
Product News

Bio-Rad Launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for Cell and Gene Therapy Production

Rapid, sensitive, and validated detection of viral replication genes using droplet digital™ PCR during cell and gene therapy production.
Advertisement